Ispecimen selected by u.s. government and private researchers to supply critical human biospecimens for advanced phase of covid-19 research

Lexington, mass., nov. 22, 2021 /prnewswire/ -- ispecimen inc. (nasdaq: ispc) ("ispecimen" or the "company"), an online marketplace for human biospecimens , today announced that it has been contracted to support new advanced research on covid-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
ISPC Ratings Summary
ISPC Quant Ranking